Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
07/2008
07/09/2008EP1942563A1 Connection member and harness connection body using the connection member
07/09/2008EP1606243B1 Process for the preapaation of chiral beta amino acid derivatives by asymmetric hydrogenation
07/09/2008CN101218020A Apparatus and method for continuously carried out equilibrium reactions
07/09/2008CN100400504C Amide derivatives as inhibitors of the enzymatic activity of renin
07/08/2008CA2331660C Process for the preparation of s-n,n'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)-amino]-2,4,6-triiodo-1,3-benzenedicarboxamide
07/08/2008CA2211939C Process for producing rhein and diacerhein
07/03/2008WO2008078102A2 Lipids and their use as non-viral delivery vehicle
07/03/2008WO2008002576A3 Prolyl hydroxylase inhibitors and methods of use
07/03/2008US20080161606 Preparation of iodixanol
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/03/2008CA2673622A1 Lipid
07/03/2008CA2673486A1 Substituted tetracycline compounds for treatment of inflammatory skin disorders
07/03/2008CA2673466A1 Substituted tetracycline compounds
07/02/2008EP1496838A4 Substituted amides
07/02/2008CN101209979A Selective hydrogenation reduction method for metacycline methacycline
07/02/2008CN101209978A Method for synthesizing dexocycline hydrochloridele from 6-methyl terramycin salt of organic acid
07/02/2008CN101209976A Substituted tartaric acid derivatives and use thereof for preparing beta-secretase inhibitor
07/02/2008CN101209974A Hydroxamic acids derivatives and use thereof
07/02/2008CN100398515C Synthesis method of isotope 15N marked L-asparagine
07/01/2008USRE40418 Treatment of neoplasms with CCI-779/EKB-569 combination
06/2008
06/26/2008WO2008076427A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
06/26/2008WO2008076259A1 Water-soluble prodrugs of florfenicol and its analogs
06/26/2008WO2008075025A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases
06/26/2008WO2008053360A3 Albumin binding molecules and uses thereof
06/26/2008WO2008002820A3 Substituted benzyl amine compounds
06/26/2008WO2007117639A3 Synthesis of tetracyclines and analogues thereof
06/26/2008CA2672792A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases
06/26/2008CA2672586A1 Water-soluble prodrugs of florfenicol and its analogs
06/25/2008EP1934171A1 Methods for preparing glutamic acid derivatives
06/24/2008US7390924 Terphenyl derivatives, preparation thereof, compositions containing same
06/24/2008US7390923 novel non-steroidal propionanilide structured compounds; useful in hormonal therapy, male hypogonadism, andropause; 3-(4-Acetylamino-3-fluorophenoxy)-2-hydroxy-2-methyl-N-(3-methyl-4-nitrophenyl)propionamide; good water solubility; beneficial androgenic effects without harmful stimulation of prostate
06/24/2008US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma
06/19/2008WO2008072745A1 Process for production of anthranilamide compound
06/19/2008WO2008072743A1 Method for producing anthranilamide compound by using novel pyrazole compound as intermediate
06/19/2008WO2008029267A3 Hydrochlorides of 3-amino-2-hydroxy carboxamides
06/18/2008EP1931629A1 Sythesis of renin inhibitors involving a cycloaddition reaction
06/18/2008EP1513803B1 Ligands that are inhibitors of the rar receptors
06/18/2008CN101203485A Amide derivative, pesticide containing such compound and use thereof
06/18/2008CN101203484A Amide derivative and pesticide containing such compound
06/18/2008CN101200450A 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
06/17/2008US7388102 photostable; protecting human hair and/or skin against damage in which UVA irradiation plays a role or is implicated
06/17/2008US7388070 inhibitors of DNA polymerase and DNA repair enzymes for treating viral infections, bacterial infections, fungal infections, protozoan infections, and neoplastic diseases; herpes viruses, herpes simplex virus (HSV), and human cytomegalovirus (CMV); peptidomimetics that mimic helical portions of proteins
06/17/2008US7388031 Reacting an epoxy compound with a aminocylcohexane-phenyl derivative; useful as anti-obesity, anti-diabetic, cicatrizing and tocolytic medicinal products
06/12/2008WO2008068615A1 Crystalline forms of ( 3 s ) -3- [n- (n' - (2-tert-butylphenyl) oxamyl) alaninyl] amino-5- (2 ', 3 ', 5 ', 6 ' -tetrafluoro phenoxy) -4-0x0penta noic acid
06/12/2008US20080139636 Adamantane derivatives
06/12/2008US20080139585 phenyl-, pyridyl-, pyrimidyl- and purine- derivatives; anticarcinogenic agent; solid tumor: breast, colorectal, lung, prostate, and ovarian
06/11/2008EP1930314A1 Process for producing carnitinamide
06/11/2008EP1930021A2 Novel amide derivatives as growth hormone secretagogues
06/11/2008CN101198584A Benzamide derivatives and uses related thereto
06/11/2008CN101198315A Manufacturing process for tigecycline
06/11/2008CN101195587A production method for lodixanol hydrolysate
06/11/2008CN101195586A Compound with substituted cyclopentane structure, production method and medicine use thereof
06/11/2008CN101195585A Compound with substituted cyclohexane structure, production method and medicine use thereof
06/11/2008CN101195584A Compound with substituted cyclopropane structure, production method and medicine use thereof
06/11/2008CN101195583A Optics pure milnacipran and production method of its salt
06/10/2008US7385085 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
06/10/2008US7384979 Substituted amino acids as erythropoietin mimetics
06/10/2008US7384925 2' Hydroxy-3'-bromo-3,4,4',5-tetramethoxy-(Z)-stilbene; antimitotic agent; inhibits the assembly of tubulin into microtubules; anticarcinogenic: solid tumor cancers, neovascularization; tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and A-4 (extract from willow tree)
06/05/2008WO2008066908A1 Processes for preparation of 9-haloacetamidominocyclines
06/05/2008WO2006138508B1 Benzamide derivatives and uses related thereto
06/05/2008US20080132706 Compounds as PDE IV and TNF Inhibitors
06/05/2008US20080132459 Inhibitors of Histone Deacetylase
06/04/2008EP1926552A1 Apparatus and method for continuously carried out equilibrium reactions
06/04/2008EP1663952B1 Abiotic heparin antagonists
06/04/2008EP1339669B1 N-alkylated gaba compounds, processes for their preparation and their use as medicaments
06/04/2008CN101193860A 有机化合物 Organic compounds
06/04/2008CN101190888A Method for preparing 5-acetamido-2,4,6-triiodo-1,3-benzenedicarboxamides
06/04/2008CN100391935C Cyclopentyl derivates
06/03/2008US7381840 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists
06/03/2008CA2421550C Process for the preparation of midodrine, pharmaceutically-acceptable salts thereof and intermediates
06/03/2008CA2334579C Secondary aspartic acid amide esters
05/2008
05/29/2008WO2008062911A1 Reagent for introduction of protein or gene
05/29/2008WO2008062859A1 Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production
05/29/2008WO2008061622A1 Crystalline forms of aliskiren hemifumarate
05/29/2008WO2008045507A3 Substituted tetracycline compounds for treatment of bacillus anthracis infections
05/29/2008US20080125598 No racemization during cyclization, decarbalkoxylation, decarboxylation of intermediate; separation of diastereoisomers by recrystallization; no use of toxic, expensive catalysts; Levetiracetam; treatment, prevention of hypoxic, ischemia of central nervous system
05/29/2008US20080125491 screening for neuroprotectants such as -Isobutyryl-1,4-a-dimethyl-1,2,3,4,4a,9,10,10a-octahydro-phenanthrene-1-carboxylic acid amide, used for the prevention of neurodegenerative diseases and cardiovascular disorders
05/29/2008US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
05/29/2008CA2668828A1 Crystalline forms of aliskiren hemifumarate
05/28/2008EP1924551A2 Organic compounds
05/28/2008EP1924541A1 Continuous crystallisation process of iodinated phenyl derivatives
05/28/2008CN101186588A Method for preparing 2,4,4'-triaminobenzoylaniline
05/28/2008CN101186587A Method for synthesizing derivative of beta-amino acid and intermediate product thereof
05/28/2008CN100390136C Abiotic heparin antagonists
05/28/2008CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties
05/27/2008US7378412 Pharmaceutical compounds
05/27/2008US7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
05/22/2008WO2008059335A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
05/22/2008US20080119556 Geranly compounds
05/22/2008US20080119512 Carboxamide Derivatives as Therapeutic Agents
05/21/2008EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
05/21/2008EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
05/20/2008US7375119 Novel inhibitor of FXa that can be administered orally; less toxic; enzyme selectivity; high bioavailability; treatment of diseases caused by thrombi or emboli; N-(5-Chloropyridin-2-yl)-5-methoxy-2-({[trans-4-(3-oxomorpholin-4-yl)cyclohexyl]carbonyl}amino)benzamide
05/20/2008US7375099 Malonamide derivatives
05/20/2008US7375093 Nuclear receptor-based inducible gene expression system
05/20/2008US7375088 culture product from a Streptomyces aizunensis strain; inhibitors of fungal cell growth and cancer cell growth; for lowering serum cholesterol and other steroids
05/20/2008US7374749 Amino substituted hydroxyphenyl benzophenone derivatives
05/20/2008CA2473759C Antibodies for detecting ecstasy-class analytes
05/20/2008CA2419698C Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes
05/20/2008CA2395717C Fused imidazolium derivatives
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 162